United States - English - NLM (National Library of Medicine)

apotex corp. - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - olopatadine hydrochloride ophthalmic solution, 0.1% is indicated for the treatment of the signs and symptoms of allergic conjunctivitis. olopatadine hydrochloride ophthalmic solution, 0.1 % is contraindicated in persons with a known hypersensitivity to olopatadine hydrochloride or any components of olopatadine hydrochloride ophthalmic solution, 0.1%.

Ireland - English - HPRA (Health Products Regulatory Authority)

apotex europe b.v. - cinacalcet hydrochloride - film coated tablet - 30 milligram - cinacalcet

Ireland - English - HPRA (Health Products Regulatory Authority)

apotex europe b.v. - cinacalcet hydrochloride - film coated tablet - 60 milligram - cinacalcet

Ireland - English - HPRA (Health Products Regulatory Authority)

apotex europe b.v. - cinacalcet hydrochloride - film coated tablet - 90 milligram - cinacalcet

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - ketorolac trometamol -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - ketorolac trometamol -

Ireland - English - HPRA (Health Products Regulatory Authority)

apotex europe b.v. - rasagiline mesilate - tablets - 1 milligram - rasagiline

Ireland - English - HPRA (Health Products Regulatory Authority)

apotex europe b.v. - solifenacin succinate - film coated tablet - 5 milligram - solifenacin

Ireland - English - HPRA (Health Products Regulatory Authority)

apotex europe b.v. - solifenacin succinate - film coated tablet - 10 milligram - solifenacin

Ireland - English - HPRA (Health Products Regulatory Authority)

apotex europe b.v. - ezetimibe - tablets - 10 milligram - ezetimibe